KalVista Pharmaceuticals ... (KALV)
NASDAQ: KALV
· Real-Time Price · USD
12.89
-0.06 (-0.46%)
At close: Aug 15, 2025, 3:59 PM
13.13
1.82%
After-hours: Aug 15, 2025, 07:39 PM EDT
KalVista Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.69M | n/a | n/a | n/a |
Cost of Revenue | -224K | n/a | n/a | n/a | 219K | 207K | 197K | 199K | 324K | 209K | 192K | 18.19M | 182K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 224K | n/a | n/a | n/a | 987K | -207K | -197K | -199K | -324K | -209K | -192K | -18.19M | -182K | n/a | n/a | n/a | 12.69M | n/a | n/a | n/a |
Operating Income | -55.03M | -42.94M | -45.81M | -44.22M | -48.45M | -33.15M | -29.75M | -29.09M | -31.73M | -26.95M | -25.88M | -26.32M | -26.81M | -26.68M | -23.6M | -19.52M | -18.04M | -12.66M | -12.78M | -14.44M |
Interest Income | 1.99M | 1.39M | 1.36M | 1.69M | 1.51M | 684K | 776K | 923K | 808K | 732K | 449K | 242K | 268K | 258K | 290K | 274K | 314K | 137K | 193K | 259K |
Pretax Income | -53.08M | -44.26M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M | -26.3M | -21.3M | -22.26M | -23.04M | -24.11M | -22.47M | -19.65M | -16.11M | -14.96M | -10.05M | -10.43M | -10.81M |
Net Income | -52.22M | -48.51M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M | -40.03M | -14.33M | -18.5M | -23.04M | -22.16M | -22.47M | -19.65M | -16.11M | -14.96M | -10.05M | -10.43M | -10.81M |
Selling & General & Admin | 39.14M | 30.35M | 29.2M | 17.6M | 23.21M | 10.42M | 10.66M | 9.79M | 7.78M | 6.88M | 7.81M | 8.13M | 7.6M | 6.95M | 6.06M | 5.85M | 6.17M | 3.56M | 3.63M | 3.28M |
Research & Development | 15.89M | 12.59M | 16.61M | 26.61M | 25.25M | 22.52M | 19.09M | 19.31M | 23.95M | 20.06M | 18.08M | 18.19M | 19.21M | 19.74M | 17.55M | 13.67M | 11.88M | 9.1M | 9.15M | 11.16M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.29M | n/a | n/a | 3.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 55.03M | 42.94M | 45.81M | 44.22M | 48.24M | 32.94M | 29.75M | 29.09M | 31.73M | 26.95M | 25.88M | 26.32M | 26.81M | 26.68M | 23.6M | 19.52M | 18.04M | 12.66M | 12.78M | 14.44M |
Interest Expense | 2.94M | 2.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -207K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 55.03M | 42.94M | 45.81M | 44.22M | 48.45M | 33.15M | 29.75M | 29.09M | 31.73M | 26.95M | 25.88M | 26.32M | 26.81M | 26.68M | 23.6M | 19.52M | 18.04M | 12.66M | 12.78M | 14.44M |
Income Tax Expense | -855K | 4.25M | n/a | n/a | 856K | n/a | n/a | n/a | 13.73M | -6.97M | -3.76M | n/a | -1.96M | n/a | n/a | n/a | -3.53M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 49.65M | 52.64M | 46.7M | 46.23M | 43.59M | 34.72M | 34.57M | 34.41M | 34.34M | 28.28M | 24.6M | 24.56M | 24.54M | 24.48M | 24.44M | 24.43M | 22.66M | 17.96M | 17.91M | 17.85M |
Shares Outstanding (Diluted) | 49.65M | 52.64M | 46.7M | 46.23M | 43.59M | 34.72M | 34.57M | 34.41M | 34.34M | 28.28M | 24.6M | 24.56M | 24.55M | 24.48M | 24.44M | 24.43M | 23.12M | 17.96M | 17.91M | 17.85M |
EPS (Basic) | -0.99 | -0.92 | -0.91 | -0.87 | -1.02 | -0.84 | -0.8 | -0.74 | -1.17 | -0.51 | -0.75 | -0.94 | -0.9 | -0.92 | -0.8 | -0.66 | -0.66 | -0.56 | -0.58 | -0.61 |
EPS (Diluted) | -0.99 | -0.92 | -0.91 | -0.87 | -1.02 | -0.84 | -0.8 | -0.74 | -1.17 | -0.51 | -0.75 | -0.94 | -0.9 | -0.92 | -0.8 | -0.66 | -0.65 | -0.56 | -0.58 | -0.61 |
EBITDA | -42.56M | -41.19M | -45.58M | -43.99M | -44.43M | -32.94M | -29.55M | -28.9M | -31.54M | -26.75M | -25.71M | -26.16M | -26.66M | -26.53M | -23.48M | -19.38M | -17.9M | -12.52M | -12.65M | -14.31M |
EBIT | -42.82M | -41.42M | -45.81M | -44.22M | -44.65M | -33.15M | -29.75M | -29.09M | -31.73M | -26.95M | -25.88M | -26.32M | -26.81M | -26.68M | -23.6M | -19.52M | -18.04M | -12.66M | -12.78M | -14.44M |
Depreciation & Amortization | 261K | 229K | 227K | 224K | 219K | 207K | 197K | 199K | 324K | 209K | 192K | 158K | 1.01M | 149K | 127K | 132K | 140K | 136K | 133K | 128K |